Clinical review 82: Androgens and the postmenopausal woman

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2759-2763

  Davis, Susan R ^a   Burger, Henry G ^b  

^a Jean Hailes Foundation for Women's Health   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ESTROGEN; GLOBULIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADRENAL GLAND; AGING; ANDROGEN SYNTHESIS; ANDROGEN THERAPY; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; HUMAN; ORAL DRUG ADMINISTRATION; OVARY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SEXUALITY; SUBCUTANEOUS DRUG ADMINISTRATION; VIRILIZATION;

ANDROGENS; FEMALE; HUMANS; MENOPAUSE; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; SEXUALITY;

EID: 0029809324     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2759     Document Type: Review

References (60)

1. Sands R, Studd J. 1995 Exogenous androgens in postmenopausal women. Am J Med. 98:765-795.
2. Kirschner MA, Bardin CW. 1972 Androgen production and metabolism in normal and virilized women. Metabolism. 21:667-688.
3. Judd HL, Yen SSC. 1973 Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab. 36:475-481.
4. Vaitukaitis JL, Dale SL, Melby JC. 1969 Role of ACTH in the secretion of free DHA and its sulphate ester in man. J Clin Endocrinol Metab. 29:1443-1447.
5. Vermeulen A. Ando S. 1978 Prolactin and adrenal androgen secretion. Clin Endocrinol (Oxf). 8:295-303.
6. Haning Jr RV, Cabot M, Flood CA, Hackett R, Longcope C. 1989 Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS) its metabolism to dehydroepiandrosterone, androstenedione testosterone and dihydrotestosterone, and the effects of increased plasma DS concentration on DS MCR in normal women. J Clin Endocrinol Metab. 69:1047-1052.
7. Parker LN, Eugene J, Farber D, Lifrale E, Lai M, Juler G. 1985a Dissociation of adrenal androgen and Cortisol levels in acute stress. Horm Metab Res. 17:209-212.
8. Parker LN, Levin ER, Lifrat ET. 1985b Evidence for adrenocortical adaption to severe illness. J Clin Endocrinol Metab. 60:947-952.
9. Zumoff B, Walsh B, Katz J, et al. 1983 Subnormal plasma dehydroepiandrosterone to cortisol ratio in anorexia nervosa: a second hormone parameter of ontogenic regression. J Clin Endocrinol Metab. 56:668-672.
10. Cunningham SK, McKenna TJ. 1994 Dissociation of adrenal androgens and cortisol secretion in Cushing's syndrome. Clin Endocrinol (Oxf). 41:795-800.
11. Dunn JF, Nisula BC, Rodbard D. 1981 Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 53:58-68.
12. Longcope C, Franz C, Morello C, Baker K, Johnston Jr CC. 1986 Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 8:189-196.
13. Rannevik G, Jeppsson S, Johnell O, et al. 1995 A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 21:103-113.
14. 13a. Burger HG, Dudley EC, Hopper DL, et al. 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab. 80:3537-3545.
15. Zumoff B, Strain GW, Miller LK, Rosner W. 1995 Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 80:1429-1430.
16. Zumoff B, Rosenfeld RS, Strain GW, et al. 1980 Sex differences in the 24-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab. 51:330-334.
17. Meldrum Dr. 1981 Changes in circulating steroids with aging in post-menopausal women. Obstet Gynecol. 57:624-628.
18. Judd HL. 1976 Hormonal dynamics associated with the menopause. Clin Obstet Gynecol. 19:775-788.
19. Judd HL, Lucas WE, Yen SS. 1974 Effect of oopherectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 118:793-798.
20. Procope B. 1968 Studies on the urinary excretion, biological effects and origin of estrogens in postmenopausal women. Acta Endocrinol (Copenh). 135:1-86.
21. Frock J, Money J. 1992 Sexuality and the menopause. Psychother Psychosom. 57:29-33.
22. Steinberg KK, Freni-titulaer LW, De Puey EG, et al. 1989 Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 69:533-539.
23. Hallstrom T. 1977 Sexuality in the climacteric. Clin Obstet Gynecol. 4:227-239.
24. McCoy NL, Davidson JM. 1985 A longitudinal study of the effects of menopause on sexuality. Maturitas. 7:203-210.
25. Utian WH. 1972 The true clinical features of postmenopausal oophorectomy and their response to estrogen replacement therapy. S Afr Med J. 46:732-737.
26. Campbell S, Whitehead M. 1977 Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol. 4:31-47.
27. Studd JWW, Chakravarti S, Oram D. 1977 The climacteric. Clin Obstet Gynecol. 4:3-29.
28. Studd JWW, Collins WP, Chakravarti S, et al. 1977 Estradiol and testosterone implants in the treatment of psychosexual problems in postmenopausal women. Br J Obstet Gynaecol. 84:314-315.
29. Sherwin BB, Gelfand MM, Brender W. 1985 Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in surgical menopause. Psychosom Med. 47:339-351.
30. Burger HG, Hailes J, Menelaus M, et al. 1984 The management of persistent symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas. 6:351-358.
31. Burger HG, Hailes J, Nelson J, Menelaus M. 1987 Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. Br Med J. 294:936-937.
32. Davis SR, McCloud P, Strauss BJG, Burger HG. 1995 Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:227-236.
33. Dow MGT, Hart DM, Forrest CA. 1983 Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol. 90:361-366.
34. Labrie F. 1991 Intracrinology. Mol Cell Endocrinol. 78:C113-C118.
35. Nilas L, Christiansen C. 1987 Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab. 65:697-699.
36. Heiss CJ, Sanborn CF, Nichols DL. 1995 Associations of body fat distribution, circulating sex hormones and bone density in postmenopausal women. J Clin Endocrinol Metab. 80:1591-1596.
37. Colvard DS, Eriksen EF, Keeting PE, et al. 1989 Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 86:854-857.
38. Kasperk CH, Wergedal JE, Farley JR, Llinkhart TA, Turner RT, Baylink DG. 1989 Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 124:1576-1578.
39. Matzkin H, Chen J, Weisman Y, et al. 1992 Prolonged treatment with finasteride (a α-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol (Oxf). 37:432-436.
40. Kasperk C, Fitzsimmons R, Strong D, et al. 1990 Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab. 71:1322-1329.
41. Yeh J, Kohimeier L, LeBoff MS, Connolly M, Glowacki J. Expression of aromatase P450 in marrow from men and postmenopausal women [Abstract]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995;OR32-2.
42. Ralston SH, Fogelman I, Leggate J, et al. 1984 Effect of sub-dermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy. Maturitas. 6:341-345.
43. Smith EP, Boyd J, Frank GR, et al. 1994 Estrogen resistance caused by a mutation in the oestrogen-receptor gene in a man. N Engl J Med. 331:1056-1061.
44. Mauras N. 1995 Estrogens do not affect whole-body protein metabolism in the prepubertal female. J Clin Endocrinol Metab. 80:2842-2845.
45. Mauras N, Haymond MW, Darmaun D, Vieira NE, Abrams SA, Yergey AL. 1994 Calcium and protein kinetics in prepubertal boys: positive effects of testosterone. J Clin Invest. 93:1014-1019.
46. Raisz LG, Wiita B, Artis A, et al. 1995 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 81:37-43.
47. Need GA, Horowitz M, Bridges A, Morris H, Nordin C. 1989 Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic women. Arch Intern Med. 149:57-60.
48. Savvas M, Studd JWW, Fogelman I, Dooley M, Montgomery J, Murby B. 1988 Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. Br Med J. 297:331-333.
49. Savvas M, Studd JWW, Norman S, Leather AT, Garnett TJ. 1992 Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol. 99:757-760.
50. Taelman P, Kayman JM, Janssens X, Vermeulen A. 1989 Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late menopause. Maturitas. 11:65-73.
51. Nordin BEC, Robertson A, Seamark RF, et al. 1985 The relation between calcium absorption serum DHEA and vertebral mineral density in postmenopausal women. J Clin Endocrinol Metab. 60:651-657.
52. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1360-1367.
53. LaRosa JC. 1995 Androgens and women's health: genetic and epidemiologic aspects of lipid metabolism. Am J Med. 98:22S-26S.
54. Whitehead M. 1994 Progestins and androgens. Fertil Steril. 62:1615-1675.
55. Ewertz M. 1988 Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer. 42:832-838.
56. Brinton LA, Hoover R, Fraumeni Jr JF. 1986 Menopausal oestrogens, and breast cancer risk: an expanded study. Br J Cancer. 54:825-832.
57. Secreto G, Toniolo P, Pisani P, et al. 1989 Androgens and breast cancer in premenopausal women. Cancer Res. 49:471-476.
58. Adlercreutz H, Hamalainen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT. 1989 Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr. 49:433-442.
59. Secreto G, Toniolo P, Berrino F, et al. 1991 Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res. 51:2572-2576.
60. Helzlsouer KJ, Gordon GB, Albert A, Bush TL, Cemstock GW. 1992 Relationship between prediagnostic serum levels of DHEA and DS to the risk of developing premenopausal breast cancer. Cancer Res. 52:1-4.